PAM
ASND icon

Pinpoint Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Pinpoint Asset Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,698
Closed -$257K – 108
2024
Q1 		$257K Buy
+1,698
New +$242K 0.04% 82

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pinpoint Asset Management's ASND Position: Q2 2024 in Review

Pinpoint Asset Management sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 1,698 shares — an estimated $257K sold.

Pinpoint Asset Management first reported a position in ASND in Q1 2024 and held it in 1 quarter. The position peaked at $257K in Q1 2024. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

  • Pinpoint Asset Management reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
  • Pinpoint Asset Management sold 1,698 Ascendis Pharma A/S shares in Q2 2024, an estimated $257K.
  • Pinpoint Asset Management first reported a position in Ascendis Pharma A/S in Q1 2024 and held it in 1 quarter.
  • Pinpoint Asset Management's Ascendis Pharma A/S position peaked at $257K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on Pinpoint Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.